(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one

C27H23ClF2N8O2 — CID 118277562

IUPAC(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
SMILESC[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)cc4cn[nH]c34)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O
InChIInChI=1S/C27H23ClF2N8O2/c1-14-3-2-4-22(20-8-15(5-6-31-20)25-21(35-26(14)40)12-34-38(25)27(29)30)37-13-32-19(10-23(37)39)18-9-17(28)7-16-11-33-36-24(16)18/h5-14,22,27H,2-4H2,1H3,(H,33,36)(H,35,40)/t14-,22+/m1/s1
InChIKeySZOMGZJNSUEMNO-PEBXRYMYSA-N
MW564.98 g/mol
LogP5.44
Rot. Bonds3

About (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one

(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one (PubChem CID 118277562) has the molecular formula C27H23ClF2N8O2 and a molecular weight of 564.98 g/mol. Its IUPAC name is (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one.

Molecular Properties

Compound Name(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
PubChem CID118277562
Molecular FormulaC27H23ClF2N8O2
Molecular Weight564.98 g/mol
Exact Mass564.16
IUPAC Name(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
SMILESC[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)cc4cn[nH]c34)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O
InChIInChI=1S/C27H23ClF2N8O2/c1-14-3-2-4-22(20-8-15(5-6-31-20)25-21(35-26(14)40)12-34-38(25)27(29)30)37-13-32-19(10-23(37)39)18-9-17(28)7-16-11-33-36-24(16)18/h5-14,22,27H,2-4H2,1H3,(H,33,36)(H,35,40)/t14-,22+/m1/s1
InChIKeySZOMGZJNSUEMNO-PEBXRYMYSA-N
XLogP5.44
TPSA123.38 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds3
Heavy Atoms40
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500564.98
LogP ≤ 55.44
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The IUPAC name of (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one (CID 118277562) is (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one.
What is the SMILES notation for (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The canonical SMILES for (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one is C[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)cc4cn[nH]c34)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O.
What is the InChIKey of (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The InChIKey is SZOMGZJNSUEMNO-PEBXRYMYSA-N. The full InChI is InChI=1S/C27H23ClF2N8O2/c1-14-3-2-4-22(20-8-15(5-6-31-20)25-21(35-26(14)40)12-34-38(25)27(29)30)37-13-32-19(10-23(37)39)18-9-17(28)7-16-11-33-36-24(16)18/h5-14,22,27H,2-4H2,1H3,(H,33,36)(H,35,40)/t14-,22+/m1/s1.
What are the key properties of (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
(9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one has a molecular weight of 564.98 g/mol, XLogP of 5.44, 3 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (9R,13S)-13-[4-(5-chloro-1H-indazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one is sourced from PubChem (CID 118277562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).